Johnson & Johnson (JNJ) stock analysis
JNJ · Johnson & Johnson
Latest recorded price: USD 282.55
Model-estimated fair value: USD 129.15. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - General
At $282.55, JNJ trades 118.8% above the model's base-case value of $129.15. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $101.63 in the conservative case and $159.04 in the optimistic case, with a valuation confidence score of 45/100. About 78% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -0.3%, free cash flow margin 20.9%, ROIC 23.6%. The model flags 1 risk signal for this company.